openPR Logo
Press release

Viscosupplementation Market projected to expand at a CAGR of ~7% from 2019 to 2027

11-05-2020 05:55 AM CET | Health & Medicine

Press release from: TransparecnyMarketResearch

Viscosupplementation Market

Viscosupplementation Market

According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in prevalence of osteoarthritis among the geriatric population across the globe. North America dominated the global viscosupplementation market in 2018 and the trend is anticipated to continue during the forecast period. Increase in awareness about new drugs for treatment and presence of major companies in the region are expected to drive the market in North America. Asia Pacific is likely to be a highly lucrative market for viscosupplementation during the forecast period.

Request Brochure for Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10232

Rise in Prevalence of Osteoarthritis among Geriatric Population and Surge in Demand for Minimally Invasive Surgery to Drive Market
Rise in prevalence of osteoarthritis across the world is a major factor boosting the growth of the global viscosupplementation market. Increase in geriatric population and high prevalence of obesity are projected to contribute to the rise in prevalence of OA, placing a major burden on individuals, health systems, and social care systems across the world. According to the Arthritis Foundation, 130 million individuals across the globe are likely to be affected by osteoarthritis by 2050. Minimally invasive surgeries minimize blood loss, reduce hospital stay, offer quicker rehabilitation, and smaller incision. Viscosupplement therapy exhibits nearly 86% success rate in alleviating pain associated with osteoarthritis.

Three Injections to Dominate Market
Based on product type, the global viscosupplementation market has been divided into single injection, three injections, and five injections. The three injections segment dominated the global viscosupplementation market in 2018 and the trend is likely to continue during the forecast period, owing to demand for three injections for better pain relief.

Request for Analysis of COVID19 Impact on Viscosupplementation Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10232

Knee Osteoarthritis to be Promising Segment
In terms of type, the global viscosupplementation market has been classified into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis. The knee osteoarthritis segment dominated the global viscosupplementation market in 2018. The growth of the knee osteoarthritis segment can be attributed to rise in the number of knee OA cases and increase in development of new drugs for pain management.
Non-animal Segment to Grow at Rapid CAGR
In terms of source, the global viscosupplementation market has been bifurcated into animal and non-animal. The animal segment dominated the global viscosupplementation market in 2018. However, the non-animal segment is expected to expand at the fastest CAGR during the forecast period.

Retail Pharmacies to be Major Distribution Channel
Based on distribution channel, the global viscosupplementation market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment dominated the global viscosupplementation market in terms of revenue in 2018 and the trend is projected to continue during the forecast period. Increase in number of viscosupplement injections being dispensed through retail pharmacies and rise in number of retail pharmacies in developing countries make these pharmacies a major channel of distribution.

BUy Viscosupplementation Market Report -
https://www.transparencymarketresearch.com/checkout.php?rep_id=10232<ype=S

Competition Landscape

Sanofi, Anika Therapeutics, Inc., Zimmer Biomet, and Chugai Pharmaceutical Co., Ltd. are the leading players in the global viscosupplementation market and hold majority market share. The global viscosupplementation market is fragmented in terms of number of players. Key players in the global market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Biomet, Ferring B.V., LG Chem, Chugai Pharmaceutical Co., Ltd., and Bioventus, Inc.New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate their business in the global viscosupplementation market.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viscosupplementation Market projected to expand at a CAGR of ~7% from 2019 to 2027 here

News-ID: 2181063 • Views:

More Releases from TransparecnyMarketResearch

Dental Fluoride Treatment Market is predicted to expand at 4.5% CAGR through 2031
Dental Fluoride Treatment Market is predicted to expand at 4.5% CAGR through 203 …
The global Dental Fluoride Treatment Market has been sailing through robust waters, witnessing a valuation of US$ 14.1 billion 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 4.5% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 21.0
Outdoor TV Market Poised to Reach US$ 866.6 Million by 2031, Driven by a 9.5% CAGR
Outdoor TV Market Poised to Reach US$ 866.6 Million by 2031, Driven by a 9.5% CA …
The global Outdoor TV Market has been sailing through robust waters, witnessing a valuation of US$ 286.8 million in 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 9.5% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 866.6
Cardiac Safety Services Market Size, Status, Scope and Growth Prospects 2020 - 2030
Cardiac Safety Services Market Size, Status, Scope and Growth Prospects 2020 - 2 …
Cardiac Safety Services Market: Introduction • Cardiac safety services can be defined as services that deal with supporting and designing clinical trials and other studies required for the monitoring of cardiac safety • Cardiac safety services are focused on monitoring the entire cardiac safety profile across various phases of clinical trials, including Phase I to Phase IV. These studies are done in compliance with FDA, PMDA, EMA, and other regulatory bodies. • Cardiovascular safety assessment services
Female Stress Urinary Incontinence Treatment Device Market set to witness surge in demand over the forecast period
Female Stress Urinary Incontinence Treatment Device Market set to witness surge …
Global Female Stress Urinary Incontinence Treatment Device Market – Overview Female stress urinary incontinence can be segmented in two ways – urethral hypermobility and intrinsic sphincter deficiency (ISD). For women suffering from urethral hypermobility, slings are the most common treatment method. However, the patient may still end up with stress urinary incontinence because of ISD. Enlarged prostate, excessive urine formation, Parkinson’s syndrome, and muscle damage are some of the key factors

All 5 Releases


More Releases for Viscosupplement

Viscosupplementation Market Worth $6.6 Billion By 2026 | CAGR 8.2% Sanofi, Zimme …
The global viscosupplementation market is estimated to reach USD 6.6 billion by 2026 growing at a CAGR of 8.2% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Viscosupplementation Market By Product Type (Single injection, Three injection, Five injection), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2026’ provides an extensive analysis of present market dynamics
viscosupplementation market in Russia is anticipated to register 6.0% CAGR durin …
Increasing risk of obesity and aging population has given rise to the cases of knee osteoarthritis. Hence viscosupplementation or injection of hyaluronic acid is a medical process in which, fluid is injected in joint. Although viscosupplement is not an alternative to surgery in emergency cases, viscosupplement can be a good treatment for knee and other joint Osteoarthritis. Viscosupplement acts slowly but lasts longer. Also, some of the studies suggest that
Viscosupplementation Market 2026 | Hyaltech, Croma-Pharma GmbH and TRB Chemedica
Increasing risk of obesity and aging population has given rise to the cases of knee osteoarthritis. Hence viscosupplementation or injection of hyaluronic acid is a medical process in which, fluid is injected in joint. Although viscosupplement is not an alternative to surgery in emergency cases, viscosupplement can be a good treatment for knee and other joint Osteoarthritis. Viscosupplement acts slowly but lasts longer. Also, some of the studies suggest that
Viscosupplementation Market Growth Evolution 2018-2026 By Top Key Players: Anika …
The global Viscosupplementation market is anticipated to reach USD 6.6 billion by 2026 according to a new research published by Polaris Market Research. Based on the assessments circulated by the World Health Organization, the worldwide people of the age of 65 years or more is estimated to ascend from 7% from 2000 to 16% till 2050. Major key Player: - Seikagaku Corporation Lifecore Biomedical LLC. Zimmer Holdings Inc Bioventus Ferring B.V. Sanofi Anika Therapeutics, Inc. LG Life Sciences Ltd. Request
Viscosupplementation Market Overview by Business Growth and Opportunities, Top C …
According to the new market research “Viscosupplementation Market [By Product Type (Single injection, Three injection, Five injection); By Regions]: Market size & Forecast, 2017 – 2026. The global Viscosupplementation market is anticipated to reach USD 6.6 billion by 2026. Based on the assessments circulated by the World Health Organization, the worldwide people of the age of 65 years or more is estimated to ascend from 7% from 2000 to 16%
Healthcare News: Viscosupplementation Market Comprehensive Analysis on Key Playe …
The global Viscosupplementation market is anticipated to reach USD 6.6 billion by 2026 according to a new research report. Based on the assessments circulated by the World Health Organization, the worldwide people of the age of 65 years or more is estimated to ascend from 7% from 2000 to 16% till 2050. Viscosupplementation is a minimally invasive procedure helps reducing the joint ache and increases the efficient condition of the osteoarthritic